Yahoo May Look to A...
Health Care: Drugs
Arrowhead Research Corporation (ARWR: NASDAQ)
$2.31 0.12 | 5.48%
05/17/13 - 04:00 PM ET
Company Balance Sheet
| Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 3.38M | 7.51M | 6.85M | 2.02M |
| Receivables | 2.47M | 1.61M | 930.68K | 147.26K |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 114.83K | 0.00 |
| Total Current Assets | 6.57M | 9.86M | 8.13M | 2.48M |
| Property, Plant & Equipment, Gross | 6.46M | 365.80K | 1.32M | 1.55M |
| Accumulated Depreciation & Depletion | 1.57M | 340.36K | 1.18M | 1.03M |
| Property, Plant & Equipment, Net | 4.90M | 25.44K | 141.27K | 527.04K |
| Intangibles | 4.78M | 1.73M | 2.05M | 2.36M |
| Other Non-Current Assets | 280.26K | 4.27M | 2.03M | 2.33M |
| Total Non-Current Assets | 9.96M | 6.03M | 4.22M | 5.22M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 16.53M | 15.89M | 12.35M | 7.70M |
| Accounts Payable | 877.99K | 576.81K | 681.56K | 1.01M |
| Short Term Debt | 214.80K | 0.00 | 0.00 | 726.53K |
| Other Current Liabilities | 2.34M | 0.00 | 2.41M | 184.35K |
| Total Current Liabilities | 5.33M | 2.58M | 4.28M | 2.34M |
| Long Term Debt | 839.42K | 606.79K | 0.00 | 500.00K |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 269.14K | 135.66K | 0.00 | 0.00 |
| Minority Interest | -984.80K | -363.51K | -1.18M | -60.00 |
| Total Non-Current Liabilities | 1.19M | 515.51K | -967.41K | 500.00K |
| Total Liabilities | 6.52M | 3.10M | 3.31M | 2.84M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 10.01M | 12.79M | 9.05M | 4.86M |
| Common Par | 108.35K | 86.42K | 71.74K | 56.43K |
| Additional Paid In Capital | 145.92M | 127.48M | 119.72M | 110.07M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -135.00M | -113.87M | -110.74M | -104.97M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | -1.02M | -900.00K | 0.00 | -300.00K |
| Total Capitalization | 10.85M | 13.40M | 9.05M | 5.36M |
| Total Equity | 10.01M | 12.79M | 9.05M | 4.86M |
| Total Liabilities & Stock Equity | 16.53M | 15.89M | 12.35M | 7.70M |
| Total Common Shares Outstanding | 13.58M | 8.64M | 7.17M | 5.64M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 11.13M | 7.18M | 6.43M | 4.52M |
| Diluted Weighted Shares Outstanding | 11.13M | 7.83M | 6.43M | 4.52M |
| Number of Employees | 52 | 57 | 18 | 20 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with ARWR
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- Usertest1123
- ContributorStocks Under-$10 Setting Up...
- UserKJP 2012 Carbon Flash Fund
- Contributor8 Penny Stocks Get Delistin...
- UserWilliam T Blanchard - Medical
- UserCaroline
- UserSimon $9000
- Usertreneehill's pennies
Latest ARWR Headlines from TheStreet
- 5 Health Care Stocks Under $10 to Watch 04.30.13 | 02:04 pm
- 5 Stocks Under $10 Set to Soar 02.28.13 | 01:02 pm
- 4 Biotech Stocks Under $10 Moving Higher 02.20.13 | 09:02 pm
- 5 Stocks Under $10 Set to Trade Higher in November 11.01.12 | 01:11 pm
- Arrowhead's Management Presents At 2012 Wedbush PacGrow Life Sciences Management Access Conference (Transcript) 08.14.12 | 09:08 pm
- Arrowhead Research Corporation's CEO Discusses F3Q12 Results - Earnings Call Transcript 08.13.12 | 08:08 pm
- Arrowhead Research's CEO Hosts Alvos Acquisition Conference Call (Transcript) 05.08.12 | 12:05 am
- 6 Stocks Hitting New 52-Week Highs 11.10.11 | 01:11 pm
- 8 Penny Stocks Get Delisting Warning 01.04.11 | 07:01 am
- Arrowhead Research CEO Discusses F4Q2010 Results  Earnings Call Transcript 12.22.10 | 09:12 pm
Press Releases for ARWR
- Arrowhead Induces 90% Reduction In Hepatitis B Antigens In Chimpanzee With Chronic Infection: Data Follow Previous Report Of Reduction In Viral DNA - Business Wire 03.25.13 | 07:03 am
- Arrowhead RNAi Candidate ARC-520 Induces Greater Than 90% Reduction In Circulating HBV DNA In Chimpanzee With Chronic Hepatitis B - Business Wire 03.14.13 | 07:03 am
- Arrowhead To Host Analyst Event In New York To Discuss RNAi-based Hepatitis B Candidate ARC-520 - Business Wire 03.07.13 | 07:03 am
- Arrowhead Receives Notice Of Patent Allowance For New Protease Sensitive Masking Chemistry For DPC SiRNA Delivery System - Business Wire 02.28.13 | 07:02 am
- Arrowhead Data Demonstrates RNAi Candidate ARC-520 Silences Hepatitis B Virus - Business Wire 02.26.13 | 09:02 am
- Arrowhead Reports Fiscal 2013 First Quarter Financial Results - Business Wire 02.13.13 | 04:02 pm
- Lifshitz Law Firm Announces Investigation Of Arrowhead Research Corp., MEI Pharma, Inc., Park City Group, Inc., And The Toro Company - PR Newswire 02.07.13 | 05:02 pm
- Arrowhead To Report Fiscal 2013 First Quarter Financial Results - Business Wire 02.06.13 | 07:02 am
- Arrowhead To Present At Upcoming Scientific Conferences - Business Wire 02.01.13 | 07:02 am
- Arrowhead Announces Pricing Of A Public Offering Of Common Stock And Warrants - Business Wire 01.25.13 | 09:01 am
Partner Headlines for ARWR
- Arrowhead Research Receives Notice of Patent Allowance for New Formulation of DPC siRNA Delivery System Showing 500-Fold Increase in Potency - Benzinga 10.16.12 | 09:10 am
- Arrowhead Sells 2.3M Shares, 1.7M Warrants for $6.2M - Benzinga 08.13.12 | 09:08 am
- Anti-Obesity Drug CAUSES Trouble for Arrowhead and 4 Stocks that Have Hit 52-Week Lows - Wall St. Cheat Sheet 06.27.12 | 10:06 am
- 4 Smaller Alternatives to Big Pharma Obesity Treatments - Benzinga 05.25.12 | 01:05 pm
- Tekmira: RNAi Company With Long Term Potential, Short Term Catalysts - Seeking Alpha 03.07.12 | 08:03 am
- Arrowhead Reports Q1 EPS of $(0.02) - Benzinga 02.10.11 | 04:02 pm
- UPDATE 1-Arrowhead co, Smith & Nephew to make cartilage product - Reuters 10.18.10 | 08:10 am
